List of Biotech, Pharmaceutical & Life Sciences companies in Arizona - 63

Amnio Technology is an industry leader in the development and manufacture of amnion-derived technologies. Amnio Technology manufactures high-quality, amnion-derived technologies for clinical use.

About Anju Anju is a customer-first organization providing adaptable life science solutions for clinical research, medical affairs, and data science. TrialMaster, IRMS MAX, and TA Scan, the company's flagship products, reduce complexities in the drug and device discovery and commercialization process allowing our customers to enhance the quality of their patients' lives. Customer First Our mission is to always be a customer-first organization, powered by a passionate team, providing best-value life science solutions paired with an excellent customer experience to simplify the complexities of life science information management. Driving Impactful Results Anju solutions are used by large, mid-sized, and small pharmaceutical companies, clinical research organizations (CROs), and medical device companies as well as full-service medical marketing, market research, and communications agencies. Our technologies facilitate data flow between our solutions and seamless communication with third-party systems, providing a unique opportunity for our customers to leverage critical information and drive impactful results. Experienced Leadership Anju is a portfolio company of Abry Partners, which is one of the most experienced and successful sector-focused private equity investment firms in North America. Since their founding in 1989, the firm has completed over $90 billion of leveraged transactions and other private equity or preferred equity placements. Currently, the firm manages over $5 billion of capital across their active funds.

Anuncia Medical is a neurotherapeutic device company currently solving the large unmet need in cerebrospinal fluid (CSF) management and neurocritical care.

Applied Biologics is a fully-integrated life sciences company providing research, product development, manufacturing and distribution of medical technologies. Since 2010, Applied Biologics has been dedicated to providing innovative biologic solutions to deliver optimal patient outcomes. The entire Applied Biologics team is dedicated to each other and the company's success. The executive team, medical advisory board, scientific advisory board, researchers, product development team, manufacturing technicians, distribution team, sales representatives, support team, reimbursement department and administrative staff are professionals and leaders in their fields. Together, we continue to strive for excellence and being a leader in delivering biological solutions to treat a growing list of medical indications.

Arizona Algae Products, LLC is a biotechnology company and algae producer in Holbrook, Arizona. We make use of proprietary production technologies and sustainable production methods to produce algal biomass and highly valuable oils from algae for use in food, dietary supplements and health products that enhance human health and improve the quality of life. We are on a mission to provide the world with the highest quality, sustainably-produced, vegetarian, omega-3 oils from algae. Omega-3 oils sourced from fish or krill raise concerns about over-fishing of our oceans or the reliance on whale food and its effect on the Antarctic ecosystem. Moreover, being animal-derived, these fish and krill oils do not fit well in a vegetarian or vegan diet. The algae we produce are sustainably grown in our own greenhouse in the high Arizona desert, using abundant sunshine, non-arable desert land and pristine saline water from the Coconino aquifer, which cannot be used for irrigation, as inputs. The oils from our algae are perfectly suited for vegetarian and vegan diets. Vegan omega-3 oils derived from flaxseed consist of ALA, which is difficult for our bodies to convert into the most important omega-3's: EPA and DHA. Instead, our algae produce EPA oil directly. Unlike other producers of algae who use outdoor raceway ponds, we grow our algae under controlled conditions in closed photobioreactors of proprietary design, resulting in the lowest possible contamination levels and the highest quality product.

Arizona Research Center was founded in 1997, to carry out reliable and meaningful clinical research for Valley residents. Since that time, over 650 clinical trials have been conducted. Our proven model, and combined years of experience, affords us the ability to provide our patients and sponsors with valuable expertise in numerous medical conditions. Our Investigators are frequently listed as lead authors of publications in medical journals, and often serve as consultants to such companies. Arizona Research Center represents an ongoing and growing network of over 100 Valley Physicians, including 50 Surgeons, and 10 Hospitals that enthusiastically support our research efforts. We take great pride in everything we do and have developed gratifying and lasting relationships with our Patients and Sponsors. Our staff includes 2 full time Principal Investigators, 1 part-time Principal Investigator, 6 Certified Clinical Research Coordinators, 4 Clinical Research Coordinators, and Research Assistants. In addition, we have a dedicated Regulatory Department offering 48-hour turnaround time, outstanding Quality Management, a committed Patient Recruiter, Marketing and Business Development, Contract Administrations, and Operations & Human Resources personnel.

Avery Therapeutics is developing first-in-class immunomodulatory therapeutics to redirect the immune system to address diseases of aging, inflammation, and fibrosis. Avery's lead program is under development for heart failure, one of the leading causes of death in the world.

Axolotl Biologix, located in Arizona is a dynamic biotech company focused on developing and producing human biologics and biological-related products to reduce inflammation and foster regeneration for many conditions that affect patients, including orthopedic, wound care, cosmetic and more. Axolotl is currently negotiating partnerships with universities and research hospitals to find ways to improve current technologies and procedures to improve patients’ quality of life.

Headquartered in Arizona, Banner Health is one of the largest nonprofit health care systems in the country. The system owns and operates 28 acute-care hospitals, Banner Health Network, Banner – University Medicine, academic and employed physician groups, long-term care centers, outpatient surgery centers and an array of other services; including Banner Urgent Care, family clinics, home care and hospice services, pharmacies and a nursing registry. Banner Health is in six states: Arizona, California, Colorado, Nebraska, Nevada and Wyoming.

Barrow Neurological Institute is a healthcare organization that specializes in preserving thoughts, memories, dreams, personalities, and movement through advanced neurological care and research.

Calviri’s mission is to provide affordable products worldwide that will end deaths from cancer. We are a fully integrated healthcare company developing a broad spectrum of vaccines and companion diagnostics that prevent and treat cancer for those either at risk or diagnosed. We focus on using frameshift neoantigens derived from errors in RNA processing to provide pioneering products against cancer. The company is a spin out of the Biodesign Institute, Arizona State University, located in Phoenix, AZ. We have the largest dog vaccine trial in the world underway at three premier veterinary universities. The five-year trial will assess the performance of a preventative cancer vaccine. For more information, please visit www.calviri.com.

Ceria Therapeutics develops innovative drug products for inflammatory disorders. We intend to transform lives by eliminating the consequences of inflammation.

Our unique platform combines a mobile app with a hypergraph data architecture. Italignsmolecular diagnostics, clinical research, pharmaceutical data and a worldwide community of other patients (and their diagnostic and treatment histories) to givehealth insights.

Clinisys is a global provider of informatics software and expertise to support diagnostic testing across healthcare, life sciences and public health. Millions of diagnostic results and data insights are generated every day using Clinisys' platform and cloud-based solutions in over 3,000 laboratories across 34 countries. Headquartered in Tucson, Arizona, and Woking, England, Clinisys' mission is to help make citizens and communities healthier and safer around the world. We're transforming the modern laboratory, providing flexible and best-in-breed solutions to help streamline workflows and improve health outcomes across nine diverse industries: healthcare, contract services, crop sciences, environment, water, food and beverage, pharma, life sciences and public health. We're committed to supporting every type of laboratory or remote testing environment – from public or private sector, in-house or outsourced. Technology is vital to future preventative approaches to health. Join us in enabling the digital transformation of diagnostics.

CND Life Sciences is dedicated to supporting the care of patients suffering from neurodegenerative diseases and other conditions. Operating a CLIA-certified and CAP-accredited laboratory in Scottsdale, AZ, CND launched the Syn-One Test® as the first commercially available test to detect, visualize, and quantify the presence of misfolded phosphorylated alpha-synuclein in cutaneous nerve fibers. The test serves as an objective diagnostic tool to aid in the confirmation of a synucleinopathy in patients with suspected Parkinson’s disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA), or pure autonomic failure (PAF). Through analysis of three small in-office skin biopsies provided by a referring physician, CND offers a convenient, accurate, minimally invasive alternative to aid in the diagnosis of neurodegenerative diseases. The company has research collaborations with multiple biopharmaceutical companies and is committed to advancing science in the field.

Cranial Technologies has been the world's leading non-surgical treatment provider for plagiocephaly (flat head syndrome) for over 35 years. It's our mission to provide exceptional treatment, experience, and outcomes for every family we treat. To date, we've cared for over 300,000 babies using our proven safe and effective DOC Band® cranial helmet. The DOC band is the first cranial helmet cleared by the FDA, and was cleared for post-surgical correction. Today, the DOC Band is the only device supported by clinical studies and 35 years of proven results. Each of our bands is custom made using state-of-the-art technology to ensure safety and comfort. Our clinics are family friendly, pediatric-focused, providing care exclusively for plagiocephaly patients. They are staffed by highly trained PTs, OTs, RNs, and Orthotists that work closely with families to achieve the best possible outcome for the babies we treat.

Creative Medical Technology Holdings, Inc., formerly Jolley Marketing, Inc., is a clinical-stage company. The Company conducts its business operations primarily through its subsidiary, Creative Medical Technologies, Inc. (CMT). The Company is engaged in stem cell research and applications for use to treat male and female sexual dysfunction, infertility, miscarriages and related issues. CMT focuses on completing the testing of its erectile dysfunction (ED) treatment and, if warranted, marketing treatment kits under the name Caverstem to physicians for use with their patients suffering from ED. CMT also intends to test and, if warranted, market licensed stem cell products under its infertility technology license. Procedures for use of the Company's ED stem cell treatment consist of a one-hour out-patient visit in a physician's office. The physician would harvest a patient's bone marrow from the hip using local anesthetic and separate the stem cells using a cell separator.

Fry Laboratories, L.L.C. is an independent clinical diagnostic and research laboratory located in Scottsdale, Arizona. We are committed to understanding chronic diseases and contributing to their cure through advancements in diagnostics and basic science research with emphasis on chronic inflammatory diseases, vector-borne diseases, and their intersection. Our clinical diagnostic laboratory offers general and targeted immunology services in conjunction with standard and cutting edge infectious disease detection and identification technologies. Our signature services include microscopy for visual identification and quantification of a wide range of blood-borne pathogens, co-infection serology, biofilm detection, and genus wide molecular detection technology with sequencing for individualized species identification. We participate in both CAP and API quality control programs and provide worldwide testing service.

GenoSensor Corporation is a genomic technology company, aiming to improve human healthcare by developing and marketing products and services for genomic research, drug discovery, predisposition gene screening, therapeutic assessment and other bioscience applications. GenoSensor's focus is to provide products and services to customers who conduct genomic research and/or are in needs of genomic solutions in all life sciences. The company also develops assays for specific applications. By means of integrating high-throughput laboratory and microarray fabrication facilities, GenoSensor has become a nationwide leading company in bioassay services and development. Currently, company's genetic products and services are helping laboratories worldwide for their sample processing, nucleic acid preparation, genetic profiling and gene screening. Full services including sample-in and data-out genomic experimentations are provided for the applications of gene expression profiling, genotyping, sequencing and other genomic research. The production pipelines are robust and highly reproducible. The service is reliable, cost-effective, and fast turnaround. Meeting the needs of individual customers is company's key goal.

Gore Medical makes medical devices used by healthcare professionals to improve the lives of patients worldwide. Come and learn more about our work.

GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 1000+ patients with brain tumors.

Heliae® Agriculture, a division of Heliae Development LLC, provides innovative microalgal products to the agricultural community. Dedicated experts in the soil and crop science fields, Heliae® Agriculture is focused on delivering regenerative agriculture solutions with its PhycoTerra® product portfolio. PhycoTerra® branded products are sourced from nature and work to improve overall soil microbial health, structure, water productivity, and nutrient use efficiency, which helps to increase crop yields sustainably for the planet, farmers, and consumers. Learn more about how PhycoTerra® pasteurized microalgal products will help achieve your regenerative agriculture objectives at www.phycoterra.com.

Henkel operates worldwide with leading innovations, brands and technologies in two business areas: Adhesive Technologies and Consumer Brands. Founded in 1876, Henkel looks back on more than 145 years of success. The company holds leading positions with its two business units in both industrial and consumer businesses thanks to strong brands, innovations and technologies such as Persil, Schwarzkopf and Loctite. Henkel, headquartered in Düsseldorf / Germany, counts among the most internationally aligned German-based companies in the global marketplace. Our company purpose expresses what unites us all at Henkel: Pioneers at heart for the good of generations. We are a diverse team of around 48,000 colleagues worldwide, striving to enrich and improve life every day through our products, services, and solutions. Our Purpose is built from our roots and carries a long-standing legacy of innovation, responsibility, and sustainability into the future. Our shared values and Leadership Commitments guide our decisions and actions every day. Imprint: http://www.henkel.com/imprint Data Privacy: https://www.henkel.com/data-protection-statement-social-media

HTG is accelerating precision medicine from diagnosis to treatment by harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas. Building on more than a decade of pioneering innovation and partnerships with biopharma leaders and major academic institutes, HTG's proprietary RNA platform technologies are designed to make the development of life science tools and diagnostics more effective and efficient and to unlock a differentiated and disruptive approach to transformative drug discovery.

Imaging Endpoints is a leading oncology-focused imaging contract research organization (iCRO) dedicated to enhancing clinical trial outcomes through advanced medical imaging. With a mission to "Connect Imaging to the Cure," the company operates 8 offices across 6 countries and employs over 40 in-house radiologists and nuclear medicine physicians, including experts in oncology imaging. Their services cover the entire spectrum of oncology trials, from translational research to Phase 3 trials, ensuring regulatory compliance and customized imaging solutions. The company offers comprehensive imaging support, including protocol development, site qualification, image acquisition, and advanced imaging analysis. Their proprietary Imaging Clinical Trial Management System (iCTMS) facilitates real-time data tracking, while the RaDAR program accelerates drug development timelines. Imaging Endpoints collaborates with a range of biopharma companies, supporting pivotal oncology trials that lead to regulatory approvals.

Jocasta Neuroscience, Inc. is a pre-clinical stage biotech company focused on developing a proprietary formulation of a-Klotho protein (JN-0413) to manage cognitive decline associated with various forms of neurodegenerative-induced dementia. Jocasta's foundational data demonstrates the critical role of a-Klotho in health and disease. Results ranging from human genetics (effect of KL mutations in humans) to robust cognitive enhancement in healthy rats, rodent disease models and non-human primates strongly support the advancement of JN-0413 into clinical trials in patients with dementia and cognitive decline.

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Machine Solutions is a provider of advanced equipment and services for the medical device, biopharmaceutical and blood- and plasma-collection industries. We have been persistent in our pursuit to add industry- leading technology leading to the unification of MSI, SteegerUSA, BW-TEC AG, Vante, PlasticWeld Systems, Crescent Design, Beahm Designs, Vela Technologies, SEBRA and Intec Automation to provide a breadth of products to support customer needs and growth. Machine Solutions provides proprietary mechanical solutions to a variety of complex process, testing and device design challenges. Our equipment has become the industry standard for balloon catheter pleat and folding, drug coated stent crimping, heart valve crimping, medical wire braiding and coiling, catheter lamination, marker band swaging, balloon forming, laser bonding, tube cutting and our thermal processing products are considered the foundational tool for a wide range of plastic manufacturing processes. As a pioneer in radio frequency technology, the company has continued to develop advancing technology for catheter tipping, bonding, flaring, flanging, hole forming, biopharmaceutical sealing, sterile connecting and disconnecting along with many other applications. Our testing products support customers to meet ISO 10555 general requirements for testing intravascular sterile use catheters with test equipment including hydraulic leak & burst testing, stent radial force testing, catheter trackability and torquability, stent securement and other testing services

Medfix® International, LLC specializes in cost effective surgical solutions in each of our subspecialties. Our subspecialties include spine retractor systems, disc preparation systems and procedure specific instruments. We work directly with healthcare facilities and distributors, putting high-quality instrumentation in the hands of surgeons in over 57 countries. Our extensive product portfolio offers a single source for spine surgery instruments. We are able to service our clients with stock availability, short lead times, as well as competitive pricing. Medfix® manufacturing capabilities are able to meet demand at any level. Our focus is cost reduction without compromising quality.

We are an advanced mass spectrometry specialty lab offering analytical services and discovery opportunities in small molecules & peptides, proteomics, and metabolomics. We support numerous animal trials (veterinary, preclinical, pK, novel API & metabolites, etc.), drug discovery markers (metabolic and drugs), toxicology, and R&D. Our R&D support offers novel research expertise in proteomics & metabolomics, including informatics analysis.

Nectero Medical is a clinical-stage biotech company pioneering novel therapies with a potential to treat aneurysmal disease and improve patients' lives.

NeoLight, LLC is a medical device company dedicated to improving neonatal care through innovative and empathy-driven solutions. The company focuses on treating preventable conditions in newborns while fostering emotional connections among healthcare providers, mothers, and infants. This holistic approach ensures that their products not only deliver medical treatment but also enhance the overall care experience. NeoLight's flagship product is the Skylife Neonatal Phototherapy System, designed to effectively treat infant jaundice. This system aims to facilitate earlier discharges and reduce re-admissions, promoting family bonding during treatment. Additionally, NeoLight offers advanced technologies such as the nëo CFM with ClearWave aEEG for enhanced brain monitoring, retinal imaging solutions for early detection of eye issues, and support for oral feeding development in newborns. The company collaborates closely with major health systems and clinicians to ensure their products meet the needs of healthcare providers and families.

NuvOx Pharma is a biotechnology company based in Tucson, Arizona that is developing a first-in-class oxygen therapeutic to treat life-threatening diseases where hypoxia plays a role. Over 30 animal studies have shown therapeutic effect in seven different indications. Phase Ib/II clinical trials in stroke and oncology demonstrated safety and evidence of efficacy, and the company is preparing to run a Phase IIa trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure (AHRF).

Leverage nVector's advanced Adeno-Associated Virus platform to quick-launch your gene therapy strategy or accelerate existing initiatives. We enhance testing and trials with superior diagnostic biomarkers.

Discover the benefits of Nucleic Acid Programmable Protein Arrays(NAPPA). The Ordinatrix team includes co-founders Prof. Josh LaBaer and Prof. Ji Qiu from Arizona State University, joined with biotech/life science executive Jim Hauert. Our goal is to be the leader in translational proteomics through the creation of the most functional, flexible, and precise protein microarrays in the industry based on our attention to quality, intellectual property, and many years of experience with the Nucleic Acid Programmable Protein Arrays (NAPPA) technology, which will aid in the development of new drugs, diagnosis of disease and approaches to personalized medicine.

Orthoscan Inc. is an American company based in Scottsdale, Arizona, founded in 2002. It specializes in orthopedic imaging solutions, focusing on the development and manufacturing of high-quality imaging devices, particularly mini and full-size C-arms. These devices are designed for surgical and clinical imaging, emphasizing advancements in dose reduction, mechanical design, and image quality. The company is dedicated to supporting the American economy by employing U.S.-based workers and sourcing parts locally. Orthoscan's product lineup includes portable mini C-arms for diagnostic purposes and full-size C-arms for more extensive surgical procedures. Additionally, they offer a mobile diagnostic imaging model tailored for clinic use, ensuring ease of portability and operation. Orthoscan's products are utilized by a diverse range of medical facilities worldwide, including clinics, hospitals, and surgery centers.

PathogenDx, Inc. (PDx) is a biotechnology company that develops testing kits, automation, and software to detect pathogens in plants, food, and the body. The company's patented multiplexed molecular testing technology, Dynamic Dimensional Detection (https://pathogendx.com/science/) or D3 Array™, can rapidly detect and identify up to 50 pathogens simultaneously, in a single well test, in less than a single shift providing triplicate data per target/analyte for confidence and certainty in results with a simple and easy process. Our technology is equipment agnostic, and our analytics is automated through our cloud-based software. Our mission is to provide testing technology and solutions for the clinical, food, and agricultural testing markets for Better and Health and safety.

With Planatome® Technology, the surgical experience has changed for both the surgeon and the patient. Our improved scalpel blades have been crafted to provide a smooth, consistent, and precise cutting surface by eliminating the grind defects found on all standard scalpels, thus minimizing surgically induced tissue trauma. Planatome Technology will provide surgeons with a more precise incision with better consistency from blade to blade, while contributing to enhanced surgical outcomes, such as faster healing with reduced infections, increased wound strength with reduced scarring, and less pain with reduced nerve damage. Planatome Technology provides an extraordinary tool for the hands of an exceptional surgeon.

Precision Trials is a network of practicing physicians comprised of investigators and research professionals dedicated to enriching the lives of furture generations through a qualitatively superior and measurable clinical trial process that focuses on the safety and protection of its subjects and the production of timely and accurate clinical data.

Prenexus Health is the exclusive manufacturer of the world's first high-fiber, sugarcane XOS prebiotic. Our fully integrated, organic supply chain ensures we are delivering the highest quality prebiotic ingredients available for food, beverage and dietary supplements. Our mission is to improve the health and wellness of individuals through the manufacturing of a high-quality, high-purity natural prebiotic ingredient grown and processed in the U.S., following sustainable environmental practices.

Quantum BioPharma is at the forefront of biotechnology, committed to advancing scientific innovation and transforming lives. Our groundbreaking research is dedicated to the development of life-saving treatments for neurodegenerative diseases, with a focus on Multiple Sclerosis (MS). Through our unwavering commitment to excellence, we are pioneering the development of Lucid-MS, a potential therapeutic aimed at remyelinating neurons in the brain and spinal cord. Our vision is to restore abilities and improve the quality of life for those affected by MS. As we advance our compounds through rigorous preclinical and clinical phases, we remain steadfast in our mission to turn scientific breakthroughs into reality. Join us in our pursuit of a brighter, healthier future, where innovation meets hope, and science saves lives.

PriZm Therapeutics is a late-stage clinical biotech company developing therapies for ultra-rare pediatric orphan diseases.

RaeSedo, Inc. is a life sciences company that focuses on identifying gaps in asthma therapeutics and uses genomics, human cells, and data to develop innovative solutions. The company has a history of collaborations in the fields of consulting, operational and financial business support, and multidisciplinary assessment and management of severe asthma.

Regenesis Biomedical is a medical device firm that develops and commercializes non-drug pain relief equipments for the treatment of chronic diseases.

Regen Suppliers sells regenerative products and services and medical devices. The biologic produces include umbilical allografts, and exosomes. The devices and equipment include ultrasound machines, shockwave, micro needling, PDO Threads, cryogenic freezers, centrifuges and more.

Reglagene is a therapeutics company that leverages its expertise in the design and development of brain penetrant medicines to create breakthrough therapies.

ReSuture's mission is to ensure safer surgery and medical device development through purpose-driven innovation. We recreate the conditions of the operating room in realistic and portable systems - creating physical models that replicate human anatomy with diseased conditions. Our medical device customers use our technology to demonstrate their products to surgeons and hospitals, ensure customer retention through ongoing training, and conduct R&D on new devices. ReSuture's patented manufacturing method allows us to create next-generation pathology-specific surgical models for vascular/endovascular, interventional radiology, structural heart, and interventional cardiology device manufacturers. Our products help ensure safer and more effective market adoption of surgical devices, and empower physicians to deliver the highest caliber of care. ReSuture is supported by the National Science Foundation to create a surgical data analytics platform that will give surgeons insight into their performance, and help medical device manufacturers better understand how providers are utilizing their devices. Movement and pressure data collected from ReSuture's models will provide the first objective, data-driven solution for training on novel medical devices.

SalutarisMD is a medical device company that specializes in engineering a novel ophthalmic treatment for Wet age-related Macular Degeneration with a minimally invasive procedure.

We're SenesTech, the rodent fertility experts and the only manufacturer of Rat Birth Control®. We are committed to improving the health of our world by humanely managing animal pest populations. Our products ContraPest® and Evolve™ interfere with the reproductive mechanisms in both male and female rats. ContraPest®, a liquid bait, is the first and only EPA-registered rodent fertility control. Evolve™, a soft bait, is a FIFRA Section 25(b) exempt minimum risk pesticide. It poses little to no risk to people, pets, and predators. Adding these products to your Integrated Pest Management (IPM) program targets the source of an infestation for long-term success.

Founded in 1938, Snell & Wilmer is a full-service business law firm with more than 500 lawyers practicing in 16 locations throughout the United States and in Mexico. The firm represents clients ranging from large, publicly traded corporations to small businesses, individuals and entrepreneurs. Snell & Wilmer and its lawyers have been recognized by clients and peers for exceptional legal skills and ethical business practices with various distinguished awards. The firm is renowned for having extensive experience in a full range of transactional and litigation legal services. The firm's range of practices include, among others: bankruptcy, bioscience, business litigation, construction, corporate, employee benefits, energy/environmental, healthcare, intellectual property, international, labor/employment, product liability, real estate/zoning, tax, and trusts/estates.

Snyder Biomedical Corporation was incorporated in 2008 by Robert W. Snyder, MD, PhD, an ophthalmologist and cell biologist, and John A. Martens.

Solera Health is committed to changing lives by guiding people to better health solutions. The company has built a dynamic platform that provides intensive, evidence-based, lifestyle and behavioral social interventions to impact the most prevalent and costly chronic conditions in the country. Solera's marketplace strategically matches members to curated networks of digital and community point solutions delivering meaningful health improvements. For payers and employers alike, the Solera Connect platform houses the most innovative health solutions in the industry all while seamlessly handling the most painful tasks involved, including, claims processing, compliance, consumer engagement, eligibility checking, member matching and vendor management.

Sonoran Biosciences is a preclinical-stage pharmaceutical company that develops antibacterial gel for the treatment of surgical site infection.

SDC delivers top-tier clinical trial services to pharmaceutical, biologic, and medical device/diagnostic companies since 2005. With industry leading strategic consulting and clinical biometrics solutions expertise at our core, our technology enabled services are fully scalable and supported via our diverse and complementary strategic partnerships to provide full service clinical trial solutions. Speak with us today to see why SDC Empowers Clinical Decisions.

SynCardia Systems, LLC, a Picard Medical Company, is headquartered in Tucson, AZ. SynCardia sells the world's first and only US Food and Drug Administration (FDA) and Health Canada approved total artificial heart as bridge to transplant for patients suffering from biventricular heart failure The SynCardia Total Artificial Heart is available in two sizes to accommodate patients’ diverse physiologies. The Freedom Portable Driver™ allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant. The SynCardia Total Artificial Heart has been successfully used in over 2,000 patients and is the most widely used and extensively studied total artificial heart in the world. For additional information and label information, visit us at www.syncardia.com.

Tesis Biosciences’ unique integrated medical platform is revolutionizing targeted genetic sequencing. Precision-based medicine to help treat major chronic diseases. Our mission is to change medicine by providing physicians, hospitals, and researchers with the tools to help patients treat and overcome major chronic conditions such as heart and lung disease, cancer, diabetes, and Alzheimer’s through advanced genetic testing. Through our collaborative efforts utilizing our unique processes, we help medical device and pharmaceutical companies bring to market products that improve the quality of life for patients.

TGen, an affiliate of City of Hope, is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments. Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics and treatments for cancer, neurological disorders, rare childhood disorders, infectious disease and other complex conditions. Stay up-to-date: tgen.org/subscribe

Medical Tube tipping, bonding and hole forming solutions from Vante and PlasticWeld enable our customers to make the world’s most precise medical devices.

By informing veterinarians and pet parents about which mutations are causing their pet's cancer to grow and spread, we intend to open up the use of precision medicine to combat canine cancer in new and more effective ways. Vidium is dedicated to unravelling the genetic components of common and complex diseases, including cancer. As a result, the practice of medicine targeting these conditions can be more rational, more precise and more personal. Our focus is on shifting paradigms in cancer treatment to enable cures for cancer and other serious diseases in pets through programs at the intersection of personalized medicine and comparative genomics.

Vomaris Innovations, Inc. is a medical device company based in Tempe, Arizona, that focuses on bioelectric technology for infection control and wound healing. Founded in 2004, the company operates globally, with its products registered in nine countries and over one million wounds treated using its technology. The company's patented V.Dox™ Technology utilizes moisture-activated microcell batteries embedded in a substrate. This technology generates a wireless electric field that mimics the body's natural healing process, targeting bacterial biofilms and reducing infection risk. Vomaris offers products such as the Procellera® Antimicrobial Wound Dressing, which is validated in numerous peer-reviewed publications, and the PowerHeal™ Antibacterial Bioelectric Bandages, available over-the-counter for superficial wounds. Their solutions are applicable in various medical fields, including chronic and acute wound care, surgical incisions, and veterinary medicine.

The acquisition of Xeridiem Medical Devices by Spectrum Plastics Group was completed in September 2016. Please follow the Spectrum Plastics Group profile for future updates. https://www.linkedin.com/company/spectrum-plastics-group/

ZelosDx, previously MSDx, Inc. is developing blood testing products to help researchers make breakthrough discoveries in brain health and disease. We seek research collaborators to license and adapt our proprietary technology for blood testing kits and automated laboratory equipment, and pharmaceutical collaborators seeking biomarker technology for drug discovery tools to be used as endpoints in their clinical trials in these neurodegenerative markets. The company is looking to make the right partnering or licensing connection!